Recent events
Recent events tied to this brand in public sources.
Back to profile1 entries
2022
Sherlock Biosciences raises $80 million in Series B financing
Sherlock Biosciences announced that it had raised $80 million in a Series B financing led by Novalis LifeSciences, with participation from new and existing investors.